| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0003 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |